YOLFTbeta
CVRx Inc

CVRx Inc

CVRX · NASDAQ · Healthcare / Medical Devices

0.6074USD-0.02 (-3.60%)

Price History

Full chart

Market Stats

Previous Close0.6301
Open0.63
Day Range0.6037 – 0.662
52-Week Range2.20 – 11.30
Volume715.78K
Market Cap67.40M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.83
Dividend Yield0.00%
Beta0.76
50-Day Avg3.68
200-Day Avg6.12

About

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Philip B. Adamson M.D., M.Sc.
  • Employees223
  • Headquarters9201 West Broadway Avenue, Minneapolis, MN, United States, 55445, USA
  • Websitehttps://www.barostim.com

Leadership

  • Dr. Philip B. Adamson M.D., M.Sc.Chief Medical Officer · b. 1961
  • Mr. Brent BinkowskiChief Operating Officer · b. 1969
  • Mr. Matt KleinVice President, Legal & Compliance Officer
  • Mr. Paul VerrastroInterim Head of Sales · b. 1963
  • Mr. Patrick LyonVice President of Marketing
  • Mr. Gregory MorrisonChief Human Resources Officer · b. 1964
  • Mr. Jared OasheimConsultant · b. 1983
  • Ms. Bonnie Handke M.B.A., R.N.Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.26M6.05M13.04M22.47M39.30M51.29M56.65M
Growth (%)--3.26%+115.36%+72.36%+74.89%+30.53%+10.45%
Cost of Revenue1.68M1.44M3.64M5.00M6.26M8.33M8.31M
Gross Profit4.57M4.61M9.40M17.47M33.04M42.96M48.34M
Gross Margin73.10%76.21%72.08%77.75%84.08%83.75%85.33%
Operating Expense14.77M16.13M35.36M60.00M76.14M102.45M99.61M
Operating Income-10.19M-11.51M-25.97M-42.53M-43.10M-59.49M-51.27M
Operating Margin-162.92%-190.22%-199.20%-189.27%-109.69%-115.98%-90.49%
EBITDA-12.78M-11.48M-40.60M-40.74M-43.10M-54.89M-46.74M
EBITDA Margin-204.32%-189.64%-311.45%-181.33%-109.69%-107.02%-82.51%
Net Income-14.63M-14.11M-43.08M-41.43M-41.20M-59.97M-53.31M
Net Income Margin-233.87%-233.09%-330.45%-184.38%-104.85%-116.91%-94.10%
R&D8.66M6.41M7.50M9.95M11.63M11.13M11.13M
R&D as % of Total Revenue138.44%105.90%57.54%44.29%29.60%21.70%19.65%
Interest Expense1.72M2.47M2.22M165.00K1.80M4.40M5.83M
Interest Expense % of Total Revenue27.49%40.81%17.02%0.73%4.58%8.57%10.29%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets29.11M64.78M152.55M124.94M115.23M133.41M104.79M
Total Liabilities308.15M358.01M6.59M15.76M39.28M62.36M65.47M
Total Equity-279.04M-293.24M145.96M109.18M75.95M71.06M39.32M
Cash25.74M59.11M142.07M106.19M90.57M105.93M75.71M
Total Debt18.99M19.28M-7.09M30.61M50.43M50.79M
Net Debt-6.75M-39.83M-142.07M-99.11M-59.96M-55.50M-24.92M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-12.79M-16.10M-27.73M-42.68M-39.02M-39.14M-40.17M
Investing Cash Flow-106.00K-311.00K-1.18M-685.00K-591.00K-1.36M-580.00K
Financing Cash Flow29.55M49.78M111.88M7.49M23.98M55.87M10.52M
Capital Expenditure106.00K311.00K1.18M685.00K591.00K1.36M580.00K
Free Cash Flow-12.89M-16.41M-28.91M-43.36M-39.61M-40.51M-40.75M
FCF to OCF100.83%101.93%104.27%101.61%101.51%103.48%101.44%

Earnings

Report DateMar 31, 2020Mar 31, 2021Jun 2, 2021Aug 4, 2021Nov 4, 2021Feb 15, 2022Apr 25, 2022Jul 28, 2022Nov 1, 2022Jan 26, 2023Apr 27, 2023Jul 25, 2023Oct 26, 2023Jan 25, 2024Apr 30, 2024Jul 29, 2024Oct 29, 2024Feb 4, 2025May 8, 2025Aug 4, 2025Nov 5, 2025Feb 12, 2026May 11, 2026Aug 6, 2026Nov 4, 2026
EPS Estimate0.000.00-0.70-21.45-0.40-0.44-0.49-0.53-0.56-0.56-0.57-0.58-0.58-0.55-0.54-0.55-0.47-0.38-0.57-0.52-0.50-0.44-0.50-0.52-0.49
EPS Actual-0.21-0.60-0.70-48.48-0.30-0.52-0.49-0.54-0.48-0.51-0.55-0.56-0.43-0.44-1.04-0.65-0.57-0.43-0.53-0.57-0.49-0.46-0.50-0.53-
Surprise--0.00%-126.01%25.00%-18.18%0.00%-1.89%14.29%8.93%3.51%3.45%25.86%20.00%-92.59%-18.18%-21.28%-13.16%7.02%-9.62%2.00%-4.55%0.00%-1.92%-
Timing---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap67.40M
Enterprise Value67.27M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.10
Price / Book3.63
EPS-1.83
Book Value0.749
Revenue (TTM)61.19M
Gross Profit (TTM)53.18M
EBITDA-47.84M
Profit Margin-84.93%
Operating Margin-82.92%
Return on Equity-133.45%
Return on Assets-28.70%
Shares Outstanding26.64M
Shares Float15.55M
Beta0.76
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 7 analystsTarget 4.58
  • Strong Buy
    5
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
65.81%
Insiders
15.20%
Retail / Other
18.99%

Top Institutional Holders

  • Johnson & Johnson
    4.02M15.11%
  • NEA Management Company, LLC
    2.03M7.61%
  • BlackRock Inc
    1.03M3.85%
  • GSK PLC
    1.01M3.78%
  • Vanguard Capital Management, LLC
    911.31K3.42%
  • Royal Bank of Canada
    706.95K2.65%
  • Balyasny Asset Management LLC
    630.81K2.37%
  • Silvercrest Asset Management Group LLC
    572.02K2.15%
  • Geode Capital Management, LLC
    427.07K1.60%
  • Partner Fund Management LP
    369.57K1.39%
  • State Street Corp
    350.55K1.32%
  • Tudor Investment Corp Et AL
    205.68K0.77%
  • The Goldman Sachs Group Inc
    201.01K0.75%
  • Northern Trust Corp
    150.12K0.56%
  • Morgan Stanley - Brokerage Accounts
    139.36K0.52%
  • Kestra Advisory Services, LLC
    132.40K0.50%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    684.12K2.57%
  • iShares Russell 2000 ETF
    366.05K1.37%
  • Fidelity Small Cap Index
    166.12K0.62%
  • iShares Russell 2000 Growth ETF
    157.20K0.59%